Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

A Look Ahead for Custom Manufacturing and Pharma

Emerging markets are an engine for growth in the custom-manufacturing and pharma markets.
Jan 2, 2014

Emerging markets are an engine for growth in the custom-manufacturing and pharma markets.

The Future of Dosage Forms

How will the move to more specialized and personalized medicines impact drug delivery and dosage forms?
Jan 2, 2014

How will the move to more specialized and personalized medicines impact drug delivery and dosage forms?

Bristol-Myers Squibb To Sell Diabetes Business to AstraZeneca

Dec 19, 2013

Bristol-Myers Squibb agrees to sell global diabetes business to AstraZeneca for $2.7 billion upfront plus an addition $1.4 billion in potential regulatory- and sales-based milestone payments.

AstraZeneca Issues Statement on Competitor to Nexium

Dec 18, 2013

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

Biogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe

Dec 18, 2013

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

Pfizer, Teva Settle Patent Litigation on Viagra

Dec 18, 2013

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

Teva Releases Financial Guidance Dependent on Copaxone Generic Competition

Dec 12, 2013

Teva Pharmaceutical Industries releases a financial outlook for 2014 based on two possible scenarios concerning its multiple-sclerosis drug Copaxone (glatiramer acetate).

GlaxoSmithKline To Invest in UK-Based Manufacturing

Dec 12, 2013

GlaxoSmithKline plans to expand its facilities in Ware and Worthing in the United Kingdom and will build a new facility for manufacturing innovation.

Applying Catalysis to Optimize API Synthesis

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.
Dec 4, 2013

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here